Minocycline hydrochloride extended release, ANDA

505(B)2 new drug for the treatment of superficial suppurative infection, including acne, tonsillitis, scapulohumeral periarthritis, folliculitis, pyoderma, gingivitis, otitis externalities, vulvitis, vaginitis, traumatic infection, postoperative infection, etc

Vascular activity

Sex hormone supplement

505(B)2 new drug, the purpose of this project is to develop the semeglutide long-acting release microspheres for injection to reach the admonition time of once a month, which can improve the compile of patients